At RSNA 2012, Philips Nuclear Medicine is introducing new clinical innovations for its positron emission tomography/computed tomography (PET/CT) systems. 

The all-new Ingenuity TF PET/CT with Astonish TF time-of-flight (TOF) performance has up to 30 percent improved contrast. Astonish TF offers a significant improvement in lesion detection compared to non-TOF scanners. With Philips proprietary Point Spread Function (PSF) technology, Ingenuity TF can improve spatial resolution to measure lesions at less than 2 mm. With iDose4, customers have the ability to improve computed tomography image quality at low dose for truly exceptional PET/CT performance.

The Ingenuity TF PET/CT builds confidence and consistency by putting users in control of:

  • Personalized patient-centric workflows that are built for high image quality at appropriate dose levels.
  • Complex and advanced procedures through a new way to work smarter by allowing users to plan the results they seek to achieve, not just the acquisitions.
  • Future innovations with a platform that will deliver CT and PET discoveries with workflow already inherent.


Ingenuity TF PET/CT is now shipping with both 64- and 128-slice configurations for greater flexibility.

For more information: www.healthcare.philips.com


Related Content

News | Radiopharmaceuticals and Tracers

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
News | FDA

Oct. 30, 2025 — Sirona Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Sirona ...

Time October 30, 2025
arrow
News | Prostate Cancer

Aug. 13, 2025 — A new study from Denmark shows for the first time that men with biochemically recurrent prostate cancer ...

Time August 15, 2025
arrow
News | Mammography

Aug. 5, 2025 — New Lantern has announced the launch of two specialized viewer modes: the Mammography Viewer Mode and PET ...

Time August 05, 2025
arrow
News | Nuclear Imaging

May 5, 2025 — GE HealthCare recently announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance ...

Time May 06, 2025
arrow
News | Prostate Cancer

July 30, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 25, 2024 — NorthStar Medical Radioisotopes, LLC and BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc ...

Time July 25, 2024
arrow
News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | ASTRO

June 21, 2024 — The American Society for Radiation Oncology (ASTRO) announced today that following a nationwide search ...

Time June 21, 2024
arrow
Subscribe Now